99% Savings - Buy Just @1 Rs X
Refract 25 Mg Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Schizophrenia. Refract 25 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Refract 25 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Refract 25 Mg Tablet include Blurred vision. Apart from the aforementioned side effects, Refract 25 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Refract 25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Refract 25 Mg Tablet's effect during pregnancy is Mild and Severe while nursing. Warnings related to Refract 25 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Refract 25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Tardive Dyskinesia, Depression, Parkinson's Disease are examples of such conditions. The section on Refract 25 Mg Tablet contraindications lists all such conditions.
Additionally, Refract 25 Mg Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Refract 25 Mg Tablet is not safe while driving, and is is not addictive in nature.
Refract 25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Refract 25 Mg Tablet safe for pregnant women?
Pregnant women may get mild side effects from Refract.
Is the use of Refract 25 Mg Tablet safe during breastfeeding?
Refract should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Refract 25 Mg Tablet on the Kidneys?
Refract rarely affects the kidneys.
What is the effect of Refract 25 Mg Tablet on the Liver?
Refract may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Refract 25 Mg Tablet on the Heart?
Refract can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Refract 25 Mg Tablet unless your doctor advises you to do so -
Is this Refract 25 Mg Tablet habit forming or addictive?
No, there is no any evidence that Refract 25 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Refract 25 Mg Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Refract 25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, Refract 25 Mg Tablet is useful in treating mental disorders.
Interaction between Food and Refract 25 Mg Tablet
Some foods when eaten with Refract 25 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Refract 25 Mg Tablet
Taking Refract 25 Mg Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Clozaril® (clozapine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 175,471
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 56-58